Target intelligence / Profile preview

House dust mite allergen Der p 2 (or Der f 2, depending on species) (Der p 2 (for Dermatophagoides pteronyssinus), Der f 2 (for Dermatophagoides farinae))

Target
Der p 2 (for Dermatophagoides pteronyssinus), Der f 2 (for Dermatophagoides farinae)
Molecular classification
Allergen, Immunoglobulin-like protein fold
01

Overview

House dust mite organism" is not a specific molecular target but refers to the entire organism. The relevant therapeutic targets are the **major allergens** produced by house dust mites, particularly proteins such as **Der p 2** and **Der f 2**, which are responsible for triggering allergic reactions in humans. These allergens have a beta-barrel structure similar to immunoglobulin folds and induce strong Th2-type immune responses that can lead to asthma, rhinitis, and eczema in susceptible individuals[1][3]. The high sequence and structural similarity between group 2 allergens from different species suggests similar biological functions across mites[4]. These proteins are not receptors or enzymes but act as environmental antigens/allergens. Note: "House dust mite organism" is too broad for a molecular target entry; the correct entries should be individual allergens such as "House dust mite allergen Der p 2".

Other names
Major house dust mite allergenGroup 2 house dust mite allergenDer p 2 (Dermatophagoides pteronyssinus)Der f 2 (Dermatophagoides farinae)
02

Biological functions

Induction of allergic immune responsesSensitization leading to Th2-type immune polarization[1]Triggering of asthma, rhinitis, and eczema in sensitized individuals[1][3]
03

Disease associations

AllergyAsthmaAtopic dermatitis/eczema[1][3]

Beyond the preview

Go deeper on House dust mite allergen Der p 2 (or Der f 2, depending on species) (Der p 2 (for Dermatophagoides pteronyssinus), Der f 2 (for Dermatophagoides farinae)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on House dust mite allergen Der p 2 (or Der f 2, depending on species) (Der p 2 (for Dermatophagoides pteronyssinus), Der f 2 (for Dermatophagoides farinae)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call